Avivagen (CVE:VIV) Shares Down 25%

Avivagen Inc. (CVE:VIV – Get Rating) shares were down 25% during mid-day trading on Friday . The company traded as low as C$0.06 and last traded at C$0.06. Approximately 106,400 shares traded hands during trading, an increase of 89% from the average daily volume of 56,321 shares. The stock had previously closed at C$0.08.

Avivagen Stock Down 25.0 %

The company has a debt-to-equity ratio of 2,402.32, a current ratio of 0.61 and a quick ratio of 0.30. The company has a market capitalization of C$4.63 million, a P/E ratio of -0.67 and a beta of 0.80. The stock has a 50-day moving average price of C$0.08 and a 200-day moving average price of C$0.11.

Avivagen (CVE:VIV – Get Rating) last issued its earnings results on Tuesday, February 21st. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$0.53 million during the quarter. On average, research analysts predict that Avivagen Inc. will post -0.06 EPS for the current fiscal year.

Avivagen Company Profile

(Get Rating)

Avivagen Inc, a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr.